Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FU9MA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,198
Award facts
- Contract value 100% obligated
- $15,197.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at approximately $15.2K, was awarded on June 28, 2025, to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens. The Defense Logistics Agency (DLA) issued this firm fixed-price, non-competitive set-aside contract with a completion deadline of June 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery at its corporate office location. This award represents a child delivery order issued against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1B prime vendor agreement running through December 2026 that establishes AmerisourceBergen as a comprehensive global pharmaceutical supplier for military and federal healthcare systems.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices. The DLA Medical Supply Chain routinely leverages this indefinite delivery contract to fulfill pharmaceutical needs across multiple therapeutic domains in support of military healthcare programs worldwide. This particular delivery order for the immunosuppressive biologic Cosentyx reflects the company's role in supplying specialized, high-value therapeutic agents to federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FU9MA?
SPE2DB25FU9MA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 28, 2025.
How much is contract SPE2DB25FU9MA worth?
The government has obligated $15,198 on SPE2DB25FU9MA.
Is contract SPE2DB25FU9MA an order under another contract?
Yes. SPE2DB25FU9MA is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9MA competed?
The extent of competition for SPE2DB25FU9MA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award